-

Clariane: Information on the Availability of a Second Amendment to the 2023 Universal Registration Document

PARIS--(BUSINESS WIRE)--Regulatory News:

Clariane (Paris:CLARI), Europe's leading community for care in times of vulnerability (the "Company"), announces that a second amendment (the "Second Amendment") to the 2023 Universal Registration Document (the "2023 Universal Registration Document") was filed on 12 June 2024 with the Autorité des marchés financiers (the "AMF") under number D. 24-0380-A02.

The Second Amendment updates a number of items in the 2023 Universal Registration Document as updated by the First Amendment filed on 31 May 2024 with the AMF under number D. 24-0380-A01 (the "First Amendment", taken together with the Second Amendment, the "Amendments"), including:

  • the information relating to risk factors (including liquidity risk, the Group's financial covenants breach risk and the management of liquidity risk, covenant breach risk and cross default risk), set out in Chapter 2 "Risk Factors" of the 2023 Universal Registration Document as updated by section 3 "Risk Factors" of the First Amendment;
  • the information relating to changes in the composition of the Board of Directors and the Committees set out in Chapter 4 "Corporate Governance" of the 2023 Universal Registration Document as updated by section 4.2 "Changes in Governance" of the First Amendment;
  • the information relating to the Company's share capital, financial delegations and authorisations, changes in share ownership and the crossing of legal thresholds, as set out in Chapter 7 "Information on the Company, share capital and shareholding structure" of the 2023 Universal Registration Document as updated by Section 6 "Information on the Company, share capital and shareholders" of the First Amendment.

Upcoming events:
5 August 2024 - Sales and results for the 1st half-year 2024
23 October 2024 - Sales for the 3rd quarter 2024

General information

The 2023 Universal Registration Document and the Amendments (in French and English) are available on Clariane's website (www.clariane.com - Investor Relations) and on the AMF website (www.amf-france.org). Copies of the 2023 Universal Registration Document and the Amendments are also available, free of charge, from the Company's registered office at 21-25, rue Balzac in Paris (8th arrondissement).

About Clariane

Clariane is Europe's leading community for care in times of need. It is present in six countries: Belgium, France, Germany, Italy, Netherlands and Spain.

With their different areas of expertise, the Group's 70,000 professionals work every year to serve almost 900,000 patients and residents in three main areas of activity: nursing homes (Korian, Seniors Residencias, etc.), healthcare establishments and services (Inicea, Ita, Grupo 5, Lebenswert, etc.) and home and alternative housing (Petits-fils, Les essentiels, Ages et Vie, etc.).

In June 2023, Clariane became a company with a mission and included a new purpose in its articles of association, common to all its activities:
"To care for the humanity of each person at times of vulnerability".

The Clariane Group is listed on Euronext Paris Section B.

Euronext ticker: CLARI.PA - ISIN: FR0010386334

Contacts

Investor contacts

Stéphane Bisseuil
Investor Relations Director
+33 (0) 6 58 60 68 69
stephane.bisseuil@clariane.com

Press contacts

Matthieu Desplats
Press Relations Director
06 58 09 01 61
matthieu.desplats@clariane.com

Florian Bachelet
Head of press relations
06 79 86 78 23
florian.bachelet@clariane.com

Julie Mary
Head of press relations
06 59 72 50 69
julie.mary@clariane.com

Clariane

BOURSE:CLARI

Release Versions

Contacts

Investor contacts

Stéphane Bisseuil
Investor Relations Director
+33 (0) 6 58 60 68 69
stephane.bisseuil@clariane.com

Press contacts

Matthieu Desplats
Press Relations Director
06 58 09 01 61
matthieu.desplats@clariane.com

Florian Bachelet
Head of press relations
06 79 86 78 23
florian.bachelet@clariane.com

Julie Mary
Head of press relations
06 59 72 50 69
julie.mary@clariane.com

More News From Clariane

Clariane: Availability and Consultation of the Information Relating to the Combined General Meeting to Be Held on 14 May 2025

PARIS--(BUSINESS WIRE)--Regulatory News: Clariane (CLARI.PA - ISIN: FR0010386334) informs its shareholders that a Combined General Meeting (the "General Meeting") of the Company will take place on Wednesday 14 May 2025 at 2 p.m. in the meeting room Apostrophe, located at 83 avenue Marceau, 75016 Paris. The prior notice of the General Meeting containing the agenda, the draft resolutions presented by the Board of Directors and the description of the participation and voting arrangements for the G...

Clariane: Information on the Availability of the 2024 Universal Registration Document

PARIS--(BUSINESS WIRE)--Regulatory News: Clariane (CLARI.PA - ISIN: FR0010386334) announces the release of its 2024 Universal Registration Document. The 2024 Universal Registration Document was filed with the French Financial Markets Authority on 31 March 2025 in ESEF format, under number D.25-0209. This 2024 Universal Registration Document, established for the financial year ended on 31 December 2024, includes in particular: - the annual financial report and the integrated report, - the report...

Clariane: Governance Evolution - Mrs Sylvia Metayer, Independent Director, Appointed Chairwoman of the Board of Directors With Effect From May 14th, 2025

PARIS--(BUSINESS WIRE)--Regulatory News: Clariane (CLARI.PA - ISIN: FR0010386334) today announces a change in its corporate governance, with the appointment of Sylvia Metayer, an independent director, as Chairwoman of the Board of Directors at the close of the Annual General Meeting on 14 May 2025. Jean-Pierre Duprieu having indicated that he did not wish to be reappointed as Director at the Annual General Meeting of 14 May 2025, in anticipation of the statutory age limit of 75, the Board of Di...
Back to Newsroom